TY  - JOUR
AU  - Hauswald, Henrik
AU  - Petrow, Eugen
AU  - Roeder, Falk
AU  - Debus, Juergen
AU  - Zwicker, Felix
AU  - Huber, Peter
TI  - Primary and adjuvant intensity-modulated radiotherapy in oropharyngeal carcinoma patients from a single institution.
JO  - Journal of cancer research and therapeutics
VL  - 20
IS  - 1
SN  - 0973-1482
CY  - Mumbai
PB  - Medknow Publications
M1  - DKFZ-2024-00626
SP  - 375 - 382
PY  - 2024
N1  - #EA:E055#LA:E055#
AB  - To retrospectively access outcome, adverse events and prognostic factors in oropharyngeal carcinoma (OPC) patients treated with intensity-modulated radiotherapy (IMRT).Ninety-eight OPC patients were treated between 2000 and 2015. Thirty-three patients received definitive and 65 adjuvant radiotherapy. Seventy-one percent had simultaneous chemotherapy. Patients were systematically followed up (mean 114 months, range 19-197 months). Statistical analysis used Kaplan-Meier method, Cox regression analysis, and log-rank test. Adverse events were classified according to common toxicity criteria version (CTCAE) 4.03.The 1-, 5-, and 10-year overall survival rates in the adjuvant vs. definitive cohort were 90.8
KW  - Humans
KW  - Radiotherapy, Intensity-Modulated: adverse effects
KW  - Radiotherapy, Intensity-Modulated: methods
KW  - Retrospective Studies
KW  - Oropharyngeal Neoplasms: radiotherapy
KW  - Oropharyngeal Neoplasms: drug therapy
KW  - Oropharyngeal Neoplasms: pathology
KW  - Radiotherapy, Adjuvant: adverse effects
KW  - Carcinoma: etiology
LB  - PUB:(DE-HGF)16
C6  - pmid:38554349
DO  - DOI:10.4103/jcrt.jcrt_2178_22
UR  - https://inrepo02.dkfz.de/record/289192
ER  -